Trial Profile
Phase 1 study of SL-801 in patients with hematologic malignancies
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Felezonexor (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 17 Nov 2016 New trial record